Guangxi Wuzhou Zhongheng Group Co., Ltd (SHA:600252)
China · Delayed Price · Currency is CNY 2.200
+0.020 (0.92%)
Jul 29, 2026, 3:00 PM CST
SHA:600252 Revenue
Guangxi Wuzhou Zhongheng Group had revenue of 355.19M CNY in the quarter ending March 31, 2026, a decrease of -31.94%. This brings the company's revenue in the last twelve months to 1.58B, down -13.12% year-over-year. In the year 2025, Guangxi Wuzhou Zhongheng Group had annual revenue of 1.75B, down -16.92%.
Revenue (ttm)
1.58B
Revenue Growth
-13.12%
P/S Ratio
4.43
Revenue / Employee
556.41K
Employees
2,843
Market Cap
7.01B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.75B | -356.17M | -16.92% |
| Dec 31, 2024 | 2.10B | -991.78M | -32.03% |
| Dec 31, 2023 | 3.10B | 382.77M | 14.10% |
| Dec 31, 2022 | 2.71B | -448.07M | -14.17% |
| Dec 31, 2021 | 3.16B | -514.55M | -14.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Northeast Pharmaceutical Group | 7.13B |
| KPC Pharmaceuticals,Inc. | 5.80B |
| Shandong Lukang Pharmaceutical | 5.71B |
| Tianjin Ringpu Bio-Technology | 3.40B |
| Jiangsu Kanion Pharmaceutical | 3.25B |
| Zhejiang Tianyu Pharmaceutical | 3.11B |
| Zhejiang Garden Biopharmaceutical | 1.19B |
| Hainan Haiyao | 792.76M |